241 related articles for article (PubMed ID: 19617405)
1. Established neointimal hyperplasia in vein grafts expands via TGF-beta-mediated progressive fibrosis.
Jiang Z; Tao M; Omalley KA; Wang D; Ozaki CK; Berceli SA
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1200-7. PubMed ID: 19617405
[TBL] [Abstract][Full Text] [Related]
2. Neointimal hyperplasia, vein graft remodeling, and long-term patency.
Wu J; Zhang C
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1194-5. PubMed ID: 19666837
[No Abstract] [Full Text] [Related]
3. Nanoparticle-mediated local delivery of an antisense TGF-β1 construct inhibits intimal hyperplasia in autogenous vein grafts in rats.
Sun DX; Liu Z; Tan XD; Cui DX; Wang BS; Dai XW
PLoS One; 2012; 7(7):e41857. PubMed ID: 22860019
[TBL] [Abstract][Full Text] [Related]
4. Induction of renal fibrotic genes by TGF-β1 requires EGFR activation, p53 and reactive oxygen species.
Samarakoon R; Dobberfuhl AD; Cooley C; Overstreet JM; Patel S; Goldschmeding R; Meldrum KK; Higgins PJ
Cell Signal; 2013 Nov; 25(11):2198-209. PubMed ID: 23872073
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta receptor type I-dependent fibrogenic gene program is mediated via activation of Smad1 and ERK1/2 pathways.
Pannu J; Nakerakanti S; Smith E; ten Dijke P; Trojanowska M
J Biol Chem; 2007 Apr; 282(14):10405-13. PubMed ID: 17317656
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of transforming growth factor-β restores endothelial thromboresistance in vein grafts.
Kapur NK; Bian C; Lin E; Deming CB; Sperry JL; Hansen BS; Kakouros N; Rade JJ
J Vasc Surg; 2011 Oct; 54(4):1117-1123.e1. PubMed ID: 21803524
[TBL] [Abstract][Full Text] [Related]
7. Profibrogenic transforming growth factor-beta/activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes.
Weng HL; Ciuclan L; Liu Y; Hamzavi J; Godoy P; Gaitantzi H; Kanzler S; Heuchel R; Ueberham U; Gebhardt R; Breitkopf K; Dooley S
Hepatology; 2007 Oct; 46(4):1257-70. PubMed ID: 17657819
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II induces connective tissue growth factor and collagen I expression via transforming growth factor-beta-dependent and -independent Smad pathways: the role of Smad3.
Yang F; Chung AC; Huang XR; Lan HY
Hypertension; 2009 Oct; 54(4):877-84. PubMed ID: 19667256
[TBL] [Abstract][Full Text] [Related]
9. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
10. Arterial gene transfer of the TGF-beta signalling protein Smad3 induces adaptive remodelling following angioplasty: a role for CTGF.
Kundi R; Hollenbeck ST; Yamanouchi D; Herman BC; Edlin R; Ryer EJ; Wang C; Tsai S; Liu B; Kent KC
Cardiovasc Res; 2009 Nov; 84(2):326-35. PubMed ID: 19570811
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of transforming growth factor-beta1, connective tissue growth factor, phosphorylated-SMAD2/3 and phosphorylated-ERK1/2 during mouse tooth development.
Li S; Pan Y
J Mol Histol; 2017 Dec; 48(5-6):347-355. PubMed ID: 28825193
[TBL] [Abstract][Full Text] [Related]
12. Simvastatin inhibits transforming growth factor-β1-induced expression of type I collagen, CTGF, and α-SMA in keloid fibroblasts.
Mun JH; Kim YM; Kim BS; Kim JH; Kim MB; Ko HC
Wound Repair Regen; 2014; 22(1):125-33. PubMed ID: 24471776
[TBL] [Abstract][Full Text] [Related]
13. Differential expression and activity of matrix metalloproteinases during flow-modulated vein graft remodeling.
Berceli SA; Jiang Z; Klingman NV; Pfahnl CL; Abouhamze ZS; Frase CD; Schultz GS; Ozaki CK
J Vasc Surg; 2004 May; 39(5):1084-90. PubMed ID: 15111865
[TBL] [Abstract][Full Text] [Related]
14. The inhibitory effect of ginsan on TGF-β mediated fibrotic process.
Ahn JY; Kim MH; Lim MJ; Park S; Lee SL; Yun YS; Song JY
J Cell Physiol; 2011 May; 226(5):1241-7. PubMed ID: 20945375
[TBL] [Abstract][Full Text] [Related]
15. The expression dynamics of transforming growth factor-β/Smad signaling in the liver fibrosis experimentally caused by Clonorchis sinensis.
Yan C; Wang L; Li B; Zhang BB; Zhang B; Wang YH; Li XY; Chen JX; Tang RX; Zheng KY
Parasit Vectors; 2015 Feb; 8():70. PubMed ID: 25649869
[TBL] [Abstract][Full Text] [Related]
16. TGF-β signalling and reactive oxygen species drive fibrosis and matrix remodelling in myxomatous mitral valves.
Hagler MA; Hadley TM; Zhang H; Mehra K; Roos CM; Schaff HV; Suri RM; Miller JD
Cardiovasc Res; 2013 Jul; 99(1):175-84. PubMed ID: 23554457
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end-products induce tubular CTGF via TGF-beta-independent Smad3 signaling.
Chung AC; Zhang H; Kong YZ; Tan JJ; Huang XR; Kopp JB; Lan HY
J Am Soc Nephrol; 2010 Feb; 21(2):249-60. PubMed ID: 19959709
[TBL] [Abstract][Full Text] [Related]
18. Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model.
Liu B; Zhang X; Zhang FC; Zong JB; Zhang W; Zhao Y
World J Gastroenterol; 2013 Sep; 19(35):5828-36. PubMed ID: 24124327
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor (TGF)-β type I receptor kinase (ALK5) inhibitor alleviates profibrotic TGF-β1 responses in fibroblasts derived from Peyronie's plaque.
Piao S; Choi MJ; Tumurbaatar M; Kim WJ; Jin HR; Shin SH; Tuvshintur B; Yin GN; Song JS; Kwon MH; Lee SJ; Han JY; Kim SJ; Ryu JK; Suh JK
J Sex Med; 2010 Oct; 7(10):3385-95. PubMed ID: 20233292
[TBL] [Abstract][Full Text] [Related]
20. Role of transforming growth factor-beta signaling pathway in pathogenesis of benign biliary stricture.
Geng ZM; Zheng JB; Zhang XX; Tao J; Wang L
World J Gastroenterol; 2008 Aug; 14(31):4949-54. PubMed ID: 18756605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
